About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Örebro Consortium
Seattle Children’s Research Institute (SCRI)
University Health Network (UHN)
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Annual Reports
Interim Reports
Financial Calendar
Events
Share issues
Analyzes
Nomination Committee
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Financial Calendar
Events
Share issues
Analyzes
Nomination Committee
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
Analyzes
No categories
The documents are only available in Swedish
2024
Analyst Group – October 2024
Mangold Insight – September 2024
Mangold Insight – June 2024
Analyst Group – March 2024
Analyst Group – January 2024
2023
Analyst Group – November 2023
Analyst Group – September 2023
Analyst Group – May 2023
Analyst Group – February 2023
2022
Analyst Group – 18 November 2022
Analyst Group – August 2022
Analyst Group – May 2022
Analyst Group – February 2022
2021
Analyst Group – August 2021
Analyst Group – May 2021
Analyst Group – April 2021
2020
Analyst Group – December 2020
Analyst Group – October 2020
